Lv11
72 积分 2023-04-06 加入
Dual-Action-Only PROTACs
2小时前
待确认
Self‐assembled Peptide‐derived Proteolysis‐targeting Chimera (PROTAC) Nanoparticles for Tumor‐targeted and Durable PD‐L1 Degradation in Cancer Immunotherapy
2天前
已完结
Polyethylene glycol immunogenicity in nanomedicine
13天前
已完结
Live vaccine development through targeted protein degradation
24天前
已完结
An immunogenic cell death dual-nanoamplifier for the reverse of chemotherapy resistance and immune escape in metastatic colon cancer
1个月前
已完结
CD36-mediated endocytosis of proteolysis-targeting chimeras
1个月前
已完结
Advancing targeted protein degradation for cancer therapy
1个月前
已完结
Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity
7个月前
已完结
Chemotherapy and the war on cancer
7个月前
已完结
皖公网安备34019202002308
